12q) was designed, synthesized and screened for their antitumor activity against SKOV-3, A549 and HeLa cell lines in vitro. Compared with the pyrrolopyrazinone( 10a) and 5-fluorouracil(5-FU), nearly all the tested compounds showed significantly-improved antitumor activities. The most promising compounds 12e and 12k(IC50=0.25 and 0.88 μmol/L) respectively show activities of 123 and 35 times that of compound 10a(IC50=30.74 μmol/L) against HeLa cell line. The result reveals that the presence of chalcone moiety is beneficial to their activity and selectivity." />
用户名: 密码: 验证码:
Design, synthesis and antitumor activity of pyrrolopyrazinone-chalcone hybrids
详细信息    查看全文
  • 作者:Ying Meng (1)
    Hongwei Zhang (1)
    Zehua Liu (1)
    Shanchao Zeng (1)
    Hongwei Zhang (1)
    Chiyu Sun (1)
    Lijuan Zhang (1)
    Mingming Zhao (1)
    Guan Wang (2)
    Mengying Jiang (2)
    Wei Shi (2)
    Hongrui Song (1)
  • 关键词:Pyrrolopyrazinone ; chalcone hybrid ; Antitumor ; Marine sponge ; Combination principle
  • 刊名:Chemical Research in Chinese Universities
  • 出版年:2014
  • 出版时间:August 2014
  • 年:2014
  • 卷:30
  • 期:4
  • 页码:624-631
  • 全文大小:510 KB
  • 参考文献:1. Francisco A. V., Lena G., / Immunopharm Immunot., 2010, / 6, 228
    2. Delphine E. N., Peter M., Thomas L., / Chem. Eur. J., 2004, / 10, 1141 CrossRef
    3. Kinnel R. B., Gehrken H. P., Swali R., Skoropowski G., Scheuer P. J., / J. Org. Chem., 1998, / 63, 3281 CrossRef
    4. Thomas L., Delphine J. E. N., Michael Z., Robin B. K., Shayna M., Matthias K., / Tetrahedron Lett., 2010, / 51, 6353 CrossRef
    5. Charlene K. M., Suzanne M., Patrick G. J., Paul C., Pauline J. E., Mathias M. D., Campbell F. C., Soraya M., Karl J. H., Mohamed E. T., / Mol. Cancer Ther., 2008, / 7, 548 CrossRef
    6. Umeyama A., Ito S., Yuasa E., Arihara S., Yamada T., / J. Nat. Prod., 1998, / 61, 1433 CrossRef
    7. Martin G. B., Andrew M. B., Anthony C. W., / New J. Chem., 1999, / 23, 687 CrossRef
    8. Meng Y., Wang G., Li Y., Hou K., Yuan Y., Zhang L. J., Song H. R., Shi W., / Chin. Chem. Lett., 2013, / 24, 619 CrossRef
    9. Herencia F., Ferrandiz M. L., Ubeda A., Domínguez J. N., Charris J. E., Lobo G. M., Alcaraz M. J., / Bioorg. Med. Chem. Lett., 1998, / 8, 1169 CrossRef
    10. Ducki S., Forrest R., Hadfield J. A., Kendall A., Lawrence N. J., McGown A. T., Rennison D., / Bioorg. Med. Chem. Lett., 1998, / 8, 1051 CrossRef
    11. Tsuchiya H., Sato M., Akagiri M., Takagi N., Tanaka T., Iinuma M., / Pharmazie, 1994, / 49, 756
    12. Go M. L., Wu X., Liu X. L., / Curr. Med. Chem., 2005, / 12, 483 CrossRef
    13. Edwards M. L., Stemerick D. M., Sunkara P. S., Michael L. E., David M. S., Prasad S. S., / J. Med. Chem., 1990, / 33, 1948 CrossRef
    14. Xie L. J., Zhai X., Liu C., Li P., Li Y. X., Guo G. X., Gong P., / Arch. Pharm. Chem., 2011, / 344, 639 CrossRef
    15. Hsu Y. L., Kuo P. L., Tzeng W. S., Lin C. C., / Food Chem. Toxicol., 2006, / 44, 704 CrossRef
    16. Nerya O., Musa R., Khatib S., Tamir S., Vaya J., / Phytochemistry, 2004, / 65, 1389 CrossRef
    17. Sabzevari O., Galati G., Moridani M. Y., Siraki A., O’Brien P. J., / Chem. Biol. Interact., 2004, / 148, 57 CrossRef
    18. Kim S. H., Lee E., Baek K. H., Kwon H. B., Woo H., Lee E. S., Kwon Y., Na Y., / Bioorg. Med. Chem. Lett., 2013, / 23, 3320 CrossRef
    19. Rao Y. K., Fang S. H., Tzeng Y. M., / Bioorg. Med. Chem., 2004, / 12, 2679 CrossRef
    20. Xie L. J., Zhai X., Ren L. X., Meng H. Y., Liu C., Zhu W. F., Zhao Y. F., / Chem. Pharm. Bull., 2011, / 59, 984 CrossRef
    21. Lv Z. L., Gao Y., Li J., Huang T.K., He S. J., Zou Y., / Chem. J. Chinese Universities, 2013, / 34(11), 2531
  • 作者单位:Ying Meng (1)
    Hongwei Zhang (1)
    Zehua Liu (1)
    Shanchao Zeng (1)
    Hongwei Zhang (1)
    Chiyu Sun (1)
    Lijuan Zhang (1)
    Mingming Zhao (1)
    Guan Wang (2)
    Mengying Jiang (2)
    Wei Shi (2)
    Hongrui Song (1)

    1. Key Laboratory of Structure-based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China
    2. Key Laboratory for Molecular Enzymology & Engineering, Ministry of Education, Jilin University, Changchun, 130012, P. R. China
  • ISSN:2210-3171
文摘
A series of pyrrolopyrazinone-chalcone hybrids(12a-strong class="a-plus-plus">12q) was designed, synthesized and screened for their antitumor activity against SKOV-3, A549 and HeLa cell lines in vitro. Compared with the pyrrolopyrazinone( 10a) and 5-fluorouracil(5-FU), nearly all the tested compounds showed significantly-improved antitumor activities. The most promising compounds 12e and 12k(IC50=0.25 and 0.88 μmol/L) respectively show activities of 123 and 35 times that of compound 10a(IC50=30.74 μmol/L) against HeLa cell line. The result reveals that the presence of chalcone moiety is beneficial to their activity and selectivity.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700